Twentyeight-Seven is Drug Discovery in United States that focus on developer business. Founded in 2016. They cover business area such as developer, drug, regulatory protein, disease, short non-coding rna, target gene expression, mrna translation, mRNA decay, small molecule, level, mirnas, health advisor, cancer initiation, progression, metastasis.
2016
( 8 years old in 2024 )
Developer
-
490 Arsenal Way
Suite 100B
Watertown, MA 02472
United States
Private
developerdrugregulatory proteindiseaseshort non-coding rnatarget gene expressionmrna translationmRNA decaysmall moleculelevelmirnashealth advisorcancer initiationprogressionmetastasis
* We use standard office opening hours in near Twentyeight-Seven's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Twentyeight-Seven is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Twentyeight-Seven business is focusing on Developer.
Twentyeight-Seven headquarter office and corporate office address is located in 490 Arsenal Way Suite 100B Watertown, MA 02472 United States.
Twentyeight-Seven was founded in United States.
In 2024, Twentyeight-Seven is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Twentyeight-Seven, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
